Race
Visit number vs Interleukin-6 soluble receptor
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 317 | 43,528.7 | ± 12,061.4 | 42,491.9 | 22,760.5 | 107,271.3 | 1 | 318 |
Follow-up | 295 | 42,149.5 | ± 11,869.9 | 41,118.2 | 22,477.1 | 103,644.5 | 6 | 301 |
Treatment Arm vs Interleukin-6 soluble receptor
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 43,528.7 | ± 12,061.4 | 42,491.9 | 22,760.5 | 107,271.3 | 1 | 318 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 106 | 42,532.2 | ± 11,785.7 | 40,387.4 | 25,641.1 | 107,271.3 | - | 106 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 105 | 44,141.7 | ± 12,371.9 | 43,949.4 | 22,760.5 | 79,836.1 | 1 | 106 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 106 | 43,917.9 | ± 12,073.9 | 43,124.7 | 23,150.9 | 92,239.8 | - | 106 |
Treatment Arm vs Interleukin-6 soluble receptor
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 295 | 42,149.5 | ± 11,869.9 | 41,118.2 | 22,477.1 | 103,644.5 | 6 | 301 |
Healthy Lifestyles and Sleep Education - control arm (HLSE) | 99 | 41,014.9 | ± 11,396.0 | 40,118.2 | 23,392.9 | 99,602.0 | 1 | 100 |
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) | 98 | 42,735.5 | ± 12,235.6 | 40,767.2 | 24,042.4 | 80,130.2 | 3 | 101 |
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) | 98 | 42,709.7 | ± 12,006.2 | 42,395.0 | 22,477.1 | 103,644.5 | 2 | 100 |
Age category vs Interleukin-6 soluble receptor
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 43,528.7 | ± 12,061.4 | 42,491.9 | 22,760.5 | 107,271.3 | 1 | 318 |
45-54 years | 53 | 44,456.5 | ± 12,765.6 | 43,293.3 | 26,461.8 | 107,271.3 | - | 53 |
55-64 years | 139 | 43,564.2 | ± 12,443.3 | 42,905.9 | 23,682.0 | 92,239.8 | - | 139 |
65 years or older | 125 | 43,095.8 | ± 11,380.7 | 40,995.7 | 22,760.5 | 79,836.1 | 1 | 126 |
Age category vs Interleukin-6 soluble receptor
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 295 | 42,149.5 | ± 11,869.9 | 41,118.2 | 22,477.1 | 103,644.5 | 5 | 300 |
45-54 years | 46 | 41,522.4 | ± 12,055.2 | 42,223.4 | 25,090.5 | 99,602.0 | 3 | 49 |
55-64 years | 125 | 42,531.3 | ± 12,634.7 | 41,248.2 | 22,477.1 | 103,644.5 | 2 | 127 |
65 years or older | 124 | 41,997.2 | ± 11,061.4 | 40,326.0 | 23,794.6 | 71,211.7 | - | 124 |
Gender of the participant vs Interleukin-6 soluble receptor
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 317 | 43,528.7 | ± 12,061.4 | 42,491.9 | 22,760.5 | 107,271.3 | 1 | 318 |
Female | 83 | 43,706.1 | ± 10,327.5 | 43,361.7 | 22,760.5 | 67,328.1 | 1 | 84 |
Male | 234 | 43,465.8 | ± 12,639.2 | 42,428.3 | 23,150.9 | 107,271.3 | - | 234 |
Gender of the participant vs Interleukin-6 soluble receptor
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 295 | 42,149.5 | ± 11,869.9 | 41,118.2 | 22,477.1 | 103,644.5 | 6 | 301 |
Female | 78 | 42,263.7 | ± 10,422.0 | 41,315.9 | 24,042.4 | 71,211.7 | 1 | 79 |
Male | 217 | 42,108.5 | ± 12,371.2 | 40,913.6 | 22,477.1 | 103,644.5 | 5 | 222 |
Race of the participant vs Interleukin-6 soluble receptor
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 43,488.8 | ± 12,059.6 | 42,431.1 | 22,760.5 | 107,271.3 | 1 | 317 |
White | 256 | 44,318.5 | ± 12,395.8 | 43,124.7 | 23,150.9 | 107,271.3 | - | 256 |
American Indian or Alaskan Native | 2 | 34,951.0 | ± 5,964.6 | 34,951.0 | 30,733.3 | 39,168.6 | - | 2 |
Black or African American | 42 | 39,000.2 | ± 10,582.2 | 39,694.6 | 22,760.5 | 65,616.8 | 1 | 43 |
Asian | 6 | 43,227.9 | ± 6,631.9 | 43,089.3 | 33,351.6 | 53,784.1 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 38,806.1 | - | 38,806.1 | 38,806.1 | 38,806.1 | - | 1 |
Other | 4 | 42,769.8 | ± 9,637.1 | 43,772.0 | 31,651.6 | 51,883.5 | - | 4 |
Multiple | 5 | 43,954.2 | ± 8,808.3 | 41,035.0 | 32,213.3 | 52,956.0 | - | 5 |
Race of the participant vs Interleukin-6 soluble receptor
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 294 | 42,095.1 | ± 11,853.3 | 41,110.9 | 22,477.1 | 103,644.5 | 5 | 299 |
White | 238 | 43,031.7 | ± 12,209.1 | 41,436.4 | 23,794.6 | 103,644.5 | 3 | 241 |
American Indian or Alaskan Native | 2 | 34,432.1 | ± 4,646.6 | 34,432.1 | 31,146.5 | 37,717.7 | - | 2 |
Black or African American | 39 | 36,893.7 | ± 9,762.3 | 35,638.0 | 22,477.1 | 71,211.7 | 2 | 41 |
Asian | 6 | 44,498.9 | ± 4,901.5 | 45,264.7 | 37,138.0 | 51,576.3 | - | 6 |
Native Hawaiian or other Pacific islander | 1 | 41,816.4 | - | 41,816.4 | 41,816.4 | 41,816.4 | - | 1 |
Other | 3 | 38,810.2 | ± 9,402.9 | 35,696.0 | 31,359.5 | 49,375.1 | - | 3 |
Multiple | 5 | 40,289.6 | ± 10,416.8 | 43,375.3 | 23,392.9 | 51,474.7 | - | 5 |